Sardano Michael's most recent trade in Sensus Healthcare Inc was a trade of 1,000 Common Stock done at an average price of $3.8 . Disclosure was reported to the exchange on Nov. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensus Healthcare Inc | Michael Sardano | Director, PRESIDENT AND GENERAL COUNSEL | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 18 Nov 2025 | 1,000 | 118,839 | - | 3.8 | 3,800 | Common Stock |
| Sensus Healthcare Inc | Michael Sardano | Director, PRESIDENT AND GENERAL COUNSEL | Purchase of securities on an exchange or from another person at price $ 4.26 per share. | 11 Nov 2025 | 1,000 | 117,839 | - | 4.3 | 4,260 | Common Stock |
| Sensus Healthcare Inc | Sardano Michael | Director, PRESIDENT AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 40,000 | 114,839 | - | 0 | Common Stock | |
| Sensus Healthcare Inc | Michael Sardano | Director, PRESIDENT AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.00 per share. | 21 Jul 2024 | 3,935 | 74,839 | - | 6 | 23,610 | Common Stock |
| Sensus Healthcare Inc | Sardano Michael | PRESIDENT AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 20,000 | 78,774 | - | 0 | Common Stock |